pqr, the primary advantages of Project Orbis is:
(1) the Sponsor only has to complete 1 application. Then, that 1 application can be submitted to the MHRA, FDA, Health Canada, and other Participating Orbis Partners (POPs), and
(2) the submission application can be reviewed almost simultaneously by multiple regulatory authorities (RAs) at the same time.
However, each RA will make their own independent approval or denial decision, based on each RA’s own timetable and based on each RA’s own approval criteria.
Bullish